Effect of a 3-Month Single-Drug Approach Using Rivaroxaban for Symptomatic Proximal Deep Vein Thrombosis-Reference-Cited by-同舟云学术

Effect of a 3-Month Single-Drug Approach Using Rivaroxaban for Symptomatic Proximal Deep Vein Thrombosis

Published:2024-06-10 Issue:6 Volume:6 Page:217-222
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Shimizu Kazuhiro¹,Sasaki Takeshi²,Todani Shunsuke¹,Ito Takuro¹,Iwakawa Masahiro¹,Sugizaki Yuta¹,Sato Shuji¹,Nakagami Takahiro¹,Mikamo Hiroshi¹,Kinoshita Toshio¹²

Affiliation:

1. Department of Internal Medicine, Toho University Sakura Medical Center

2. Clinical Physiological Function Laboratory, Toho University Sakura Medical Center

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circrep/6/6/6_CR-24-0042/_pdf

Reference10 articles.

1. 1. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012; 379: 1835–1846, doi:10.1016/S0140-6736(11)61904-1.

2. 2. Schein JR, White CM, Nelson WW, Kluger J, ElMearns ES, Coleman CI. Vitamin K antagonist use: Evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences. Thromb J 2016; 14: 14, doi:10.1186/s12959-016-0088-y.

3. 3. EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499–2510, doi:10.1056/NEJMoa1007903.

4. 4. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369: 799–808, doi:10.1056/NEJMoa1302507.

5. 5. Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369: 1406–1415, doi:10.1056/NEJMoa1306638.